Triple-negative breast cancer (TNBC) is a subtype characterized by the lack of expression of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2(HER2). This evidence concerns the gene PGR and triple-negative breast carcinoma.